# Efficacy/Safety of HA Inhalation Solution for Hereditary Emphysema in Patients With Alpha-1 Antitrypsin Deficiency

> **NCT03114020** · PHASE2 · COMPLETED · sponsor: **Gerard Turino** · enrollment: 27 (actual)

## Conditions studied

- Emphysema
- Alpha 1-Antitrypsin Deficiency

## Interventions

- **DRUG:** Hyaluronic Acid Inhalation Solution
- **DRUG:** Placebo Inhalation Solution

## Key facts

- **NCT ID:** NCT03114020
- **Lead sponsor:** Gerard Turino
- **Sponsor class:** INDIV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-22
- **Primary completion:** 2019-11-12
- **Final completion:** 2019-11-12
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2020-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03114020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03114020, "Efficacy/Safety of HA Inhalation Solution for Hereditary Emphysema in Patients With Alpha-1 Antitrypsin Deficiency". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03114020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*